* 40% of all prescription drugs on the market target GPCRs.
* Expressed in all tissues, so being investigated for many diseases.
* Cancer, cardiac care, diabetes, obesity, CNS disorders, pain and inflammation.
* Most GPCR drugs were identified on the basis of their activity in a functional assay.
* Not rationally designed based on structure.
* A simple model such as C. *elegans* may be a tool to understand human disease and identify new drugs.